Skip to main content
Move with Meaning: A Guide to Dementia Care, Planning & Transition
Monday, Nov. 2nd 8am-9am : RSVP Here!

New Parkinson’s Drug Tavapadon: What Families Should Know

The new Parkinson’s drug tavapadon, marketed as Juvmo, received FDA approval on September 25, 2026. This once-daily prescription medication helps manage Parkinson’s movement symptoms, including tremors, stiffness, and slowed movement.

For families supporting a loved one with Parkinson’s, the approval offers another treatment option worth discussing with a neurologist. While tavapadon is not a cure, clinical trials suggest it may improve symptom control and daily functioning.

Key Takeaways About Tavapadon

  • New FDA-approved medication: Tavapadon, sold as Juvmo, is a once-daily oral treatment for adults with Parkinson’s disease.
  • Improved movement symptoms: Clinical trials found improvements in motor symptoms and everyday functioning.
  • More time with controlled symptoms: When added to levodopa, tavapadon provided approximately one additional hour of daily “on” time without troublesome involuntary movements.
  • Potential side effects: Nausea, headaches, dizziness, hallucinations, and blood pressure changes are important considerations.
  • Individualized care remains essential: Treatment decisions should reflect each person’s symptoms, medical history, and current medications.

Our Promise is to love and care for your family as we do our own.

Tavapadon vs. Levodopa: What’s the Difference?

Tavapadon and levodopa both help manage Parkinson’s motor symptoms, but they work differently.

FeatureTavapadon (Juvmo)Levodopa
How it worksDirectly activates certain dopamine receptorsConverts into dopamine in the brain
Treatment roleMay be used alone or alongside levodopaCommonly used as a primary treatment
AdministrationUsually taken once dailyDosing depends on formulation and individual needs
ConsiderationsMay cause nausea, dizziness, hallucinations, or impulse control changesMay cause nausea, involuntary movements, or fluctuations in symptom control

Neither medication is necessarily better for every individual. Tavapadon offers another option for neurologists to consider when tailoring Parkinson’s treatment.

Supporting Your Loved One Through Changing Care Needs

At Kensington Place Redwood City, we know that neurological conditions can bring new questions about daily care and long-term well-being.

If your loved one is experiencing Parkinson’s-related memory loss or dementia, our specialized memory care neighborhoods offer personalized support in a welcoming community.

Explore Memory Care at Kensington Place Redwood City

How Does the New Parkinson’s Drug Tavapadon Work?

Parkinson’s disease affects nerve cells that produce dopamine, a brain chemical that helps coordinate movement.

As dopamine levels decline, individuals may experience tremors, muscle stiffness, slower movements, and difficulty with coordination.

Tavapadon belongs to a medication class called dopamine agonists. Rather than replacing dopamine, these medications activate dopamine receptors, helping the brain regulate movement.

What Makes Tavapadon Different?

Tavapadon primarily targets D1 and D5 dopamine receptors, which play important roles in controlling movement.

This selective approach differs from older dopamine agonists in two key ways:

  1. More targeted receptor activity: Tavapadon targets movement-related receptors, whereas many older dopamine agonists act on a broader range of dopamine receptors.
  2. Potential for fewer side effects: Researchers believe this selectivity could reduce certain unwanted effects associated with older treatments.

However, fewer side effects have not been proven. Tavapadon has not been directly compared with older dopamine agonists in clinical trials.

According to the Michael J. Fox Foundation, the approval expands the treatment options available to people living with Parkinson’s.

Learn more about emerging treatments in our article on innovations in Parkinson’s care.

What Did Clinical Trials Reveal About Tavapadon?

The FDA approval was supported by three Phase III clinical trials: TEMPO-1, TEMPO-2, and TEMPO-3.

These studies examined whether tavapadon could improve Parkinson’s symptoms at different stages of the disease.

TEMPO-1 and TEMPO-2: Benefits in Earlier Parkinson’s

These trials studied individuals diagnosed with Parkinson’s within the previous three years who were not taking dopamine-based medications.

Compared with placebo, tavapadon improved movement symptoms and daily functioning.

Researchers evaluated abilities such as:

  • Getting dressed
  • Eating meals
  • Managing personal hygiene
  • Completing everyday movements

These findings suggest tavapadon may help some individuals manage symptoms during earlier stages of Parkinson’s.

TEMPO-3: Less “Off” Time During the Day

TEMPO-3 focused on individuals with progressing Parkinson’s who were already taking levodopa.

Some experienced periods when their medication became less effective before the next dose. These periods are known as “off” time, when symptoms return or become more noticeable.

Adding tavapadon to levodopa produced two important results:

  • Approximately 1 additional hour of daily “on” time, with symptomscontrolled without troublesome dyskinesia.
  • Approximately one hour less daily “off” time, when symptoms were not adequately controlled.

Dyskinesia refers to involuntary movements that can occur during Parkinson’s treatment.

These results represent study averages, and individual responses may differ.

Why These Findings Matter to Families

More predictable symptom control may help individuals participate more comfortably in their daily routines.

For someone experiencing frequent movement difficulties, even modest improvements may make activities such as dressing, eating, or spending time with loved ones more manageable.

However, better movement control does not eliminate other Parkinson’s symptoms or the need for ongoing medical support.

What Are the Potential Side Effects of Tavapadon?

Understanding medication risks is especially important when supporting an older loved one.

According to the FDA-approved Juvmo prescribing information, side effects vary depending on whether tavapadon is taken alone or with levodopa.

Commonly Reported Side Effects

For people taking tavapadon without levodopa, commonly reported side effects included:

  • Nausea and vomiting
  • Headaches
  • Dizziness
  • Fatigue
  • Changes in taste
  • Dry mouth
  • Anxiety

When tavapadon was taken with levodopa, dyskinesia, hallucinations, and low blood pressure upon standing were also among the more commonly reported reactions.

Important Changes Families Should Watch For

Some side effects deserve particular attention because they can affect daily safety and well-being.

  • Dizziness or low blood pressure: Feeling lightheaded when standing may increase the risk of falls.
  • Excessive sleepiness: Tavapadon may cause significant daytime drowsiness or sudden episodes of sleep, which can pose safety risks during daily activities.
  • Hallucinations: A loved one may see, hear, or sense things that are not present. New hallucinations should be reported to their clinician.
  • Impulse control changes: Dopamine agonists can contribute to compulsive behaviors, including excessive shopping, gambling, or eating.
  • Involuntary movements: Tavapadon may cause or worsen dyskinesia, particularly when combined with other Parkinson’s medications.

Families should communicate any concerning changes to the prescribing clinician.

Should Families Be Concerned About Long-Term Safety?

Tavapadon’s approval is encouraging, but ongoing research remains important. Its safety profile cannot be directly compared with that of other dopamine agonists from separate clinical trials.

The TEMPO-4 study is gathering additional information about longer-term treatment outcomes.

Families should also review all existing medications with their loved one’s neurologist because tavapadon has clinically important drug interactions.

Do not start, stop, or adjust Parkinson’s medication without professional medical guidance.

How Could Tavapadon Affect Everyday Life With Parkinson’s?

For many families, successful treatment means more than just reducing symptoms on a medical assessment. It means helping a loved one maintain comfort, independence, and opportunities for meaningful connection.

When movement symptoms are better controlled, everyday activities may become easier to manage.

These may include:

  • Personal care: Dressing, grooming, and eating with greater ease.
  • Mobility: Completing familiar movements with fewer symptom-related interruptions.
  • Social engagement: Participating more comfortably in family gatherings and favorite activities.
  • Daily routines: Planning activities around more predictable periods of symptom control.

These are potential benefits of improved movement management, not guaranteed outcomes of tavapadon.

Why Comprehensive Parkinson’s Care Still Matters

Parkinson’s can affect movement, sleep, mood, communication, swallowing, and thinking.

A personalized care plan may include medication alongside:

  • Physical and occupational therapy
  • Speech and swallowing support
  • Appropriate exercise and movement
  • Nutritional guidance
  • Regular neurological evaluations
  • Emotional and family caregiver support

Families can also benefit from understanding how daily habits influence overall wellness.

Learn more in our guide to diet and lifestyle considerations for Parkinson’s disease.

When Parkinson’s Care Needs Begin to Change

Sometimes, new challenges arise even when movement symptoms are being treated.

If your loved one is experiencing significant memory changes, confusion, or dementia, specialized memory care may provide additional support.

At Kensington Place Redwood City, we take time to understand each resident’s abilities, preferences, and evolving needs.

Contact Our Team to Discuss Care Options

Parkinson’s Disease, Memory Changes, and Specialized Care

Although Parkinson’s is best known for its movement symptoms, some individuals also develop changes in memory, thinking, and behavior.

Not everyone with Parkinson’s develops dementia. However, when cognitive changes begin affecting daily safety, independence, or personal care, families may need additional guidance.

When Might Memory Care Be Appropriate?

Families may consider specialized memory care when a loved one experiences:

  • Increasing confusion or disorientation
  • Difficulty completing familiar tasks
  • Wandering or becoming lost
  • Changes in judgment that affect safety
  • Greater dependence on others for daily activities
  • Cognitive or behavioral challenges that are difficult to manage at home

New or worsening confusion should be evaluated by a clinician first. Medication effects and other medical conditions may contribute to these changes.

The decision to explore memory care should reflect a loved one’s actual cognitive and daily support needs, not their Parkinson’s diagnosis alone.

Personalized Memory Care at Kensington Place Redwood City

Our memory care community features two specialized neighborhoods designed to support residents at different stages of dementia.

Connections: Early to Middle-Stage Memory Care

Connections supports residents experiencing early to middle-stage memory loss.

We focus on:

  • Preserving familiar routines
  • Encouraging purposeful engagement
  • Supporting each resident’s independence

Our team members learn about residents’ personal histories, interests, and preferences to help create meaningful daily experiences.

Haven: Advanced Memory Care

Haven supports residents experiencing more advanced memory loss who need greater assistance with everyday activities.

Our approach emphasizes:

  • Comfort
  • Dignity
  • Safety
  • Compassionate personal attention

We adapt support to each resident’s abilities while encouraging moments of connection with loved ones.

A Community That Supports Families, Too

Decisions about memory care can be emotional. Families may be balancing safety concerns, caregiving responsibilities, and a desire to preserve their loved one’s independence.

Our team members are here to listen, answer questions, and help families understand the support available.

At Kensington Place Redwood City, personalized memory care means recognizing the individual beyond the diagnosis.

Questions to Ask Your Loved One’s Neurologist About Tavapadon

If your loved one is experiencing Parkinson’s symptoms that are difficult to manage, consider bringing these questions to their next medical appointment.

1. Is Tavapadon Appropriate for My Loved One?

Ask how their current symptoms, medical history, and treatment goals influence eligibility.

2. Could Tavapadon Interact With Existing Medications?

Provide an updated medication list, including prescription drugs, supplements, and over-the-counter products.

3. Which Side Effects Should We Monitor?

Discuss symptoms such as dizziness, hallucinations, blood pressure changes, and unusual behaviors.

4. How Will We Measure Treatment Success?

Ask whether tracking movement symptoms, “off” time, or everyday activities could help evaluate treatment effectiveness.

5. What Should We Know About Availability and Insurance?

The FDA approved tavapadon in September 2026, but pharmacy availability and insurance coverage may vary.

Ask the neurologist and pharmacy about current access and potential out-of-pocket costs.

FAQs: Tavapadon for Parkinson’s

Is Tavapadon a Cure for Parkinson’s Disease?

No. Tavapadon helps manage Parkinson’s symptoms but has not been shown to cure the disease or stop its progression.

Can Tavapadon Be Used With Levodopa?

Yes. Clinical trials studied tavapadon as an additional treatment for individuals already taking levodopa. A neurologist can determine whether the combination is appropriate.

Does Tavapadon Treat Parkinson’s-Related Dementia?

No. Tavapadon is not approved to treat dementia. Parkinson’s-related cognitive changes require individualized medical evaluation and may benefit from specialized support.

Moving Forward With Hope and Personalized Care

The approval of the new Parkinson’s drug tavapadon represents meaningful progress in managing Parkinson’s symptoms. For families, it offers another treatment option to explore with a neurologist.

At Kensington Place Redwood City, we welcome advancements that may improve quality of life. We also understand that as neurological conditions progress, families may need additional guidance and support.

Explore Compassionate Memory Care at Kensington Place Redwood City

If your loved one is experiencing Parkinson’s-related dementia or other forms of memory loss, our Connections and Haven neighborhoods provide specialized care in a warm, welcoming community.

We would be honored to learn your family’s story, answer your questions, and help you explore the next steps.

Schedule a Private Tour of Kensington Place Redwood City